Carrick Therapeutics
ID: 6700462Transforming cancer treatments and the lives of cancer patients by targeting the molecular pathways that drive the most aggressive and resistant forms of cancer.
4
Funding Rounds
$345.0m
Money raised
Recent Funding Rounds
Overview
Transforming cancer treatments and the lives of cancer patients by targeting the molecular pathways that drive the most aggressive and resistant forms of cancer.
- Website:
- Business model: B2C
- Headquarters: Dublin
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Carrick Therapeutics has raised a total of $345m in funding over 4 rounds.
Key Insights:
- Carrick Therapeutics December 2022 Series C Funding Round: $60m
- Carrick Therapeutics October 2016 Series A Funding Round: $95m
- Carrick Therapeutics October 2016 Series A Funding Round: $95m
- Carrick Therapeutics , October 2016: $95m
Industries
Carrick Therapeutics is active in the following industries: